OPKO Health, Inc. Defined Contribution Plan, Cost
OPKO Health, Inc. (OPK) reported Defined Contribution Plan, Cost of $600.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2015-02-27
- OPKO Health, Inc. defined contribution plan, cost for fiscal 2014 was $600.00K, a 20.00% increase from fiscal 2013.
- OPKO Health, Inc. defined contribution plan, cost for fiscal 2013 was $500.00K, a 66.67% increase from fiscal 2012.
- OPKO Health, Inc. defined contribution plan, cost for fiscal 2012 was $300.00K, a 50.00% increase from fiscal 2011.
- OPKO Health, Inc. defined contribution plan, cost for fiscal 2011 was $200.00K.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2014-12-31 | $600.00K 10-K · filed 2015-02-27 |
| 2013-12-31 | $500.00K 10-K · filed 2015-02-27 |
| 2012-12-31 | $300.00K 10-K · filed 2015-02-27 |
| 2011-12-31 | $200.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |